ServiceNow [NOW]
As of 2026-07-29. Sources: Alpha Vantage normalized statements (64 quarterly periods), the Q2 2026 10-Q
(0001373715-26-000076, filed 2026-07-23), the Q2 2026 earnings release 8-K (0001373715-26-000072,
erq2fy26.htm, filed 2026-07-22), nine EARNINGS_CALL_TRANSCRIPT pulls, and Alpaca for prices and options.
All figures $m. S&M and G&A are from the filed income statement, not from Alpha Vantage — see defect 2.
| Period | Revenue | Gross profit | GM% | S&M | R&D | G&A | GAAP EBIT | OM% |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3,987 | 2,818 | 70.7% | 1,372 | 915 | 369 | 162 | 4.1% |
| 2026-03-31 | 3,770 | 2,830 | 75.1% | 1,216 | 823 | 288 | 503 | 13.3% |
| 2025-12-31 | 3,568 | 2,734 | 76.6% | 1,150 | 773 | 368 | 443 | 12.4% |
| 2025-09-30 | 3,407 | 2,633 | 77.3% | 1,056 | 750 | 255 | 572 | 16.8% |
| TTM | 14,732 | 11,015 | 74.77% | 4,794 | 3,261 | 1,280 | 1,680 | 11.40% |
| 2025-06-30 | 3,215 | 2,491 | 77.5% | 1,128 | 734 | 271 | 358 | 11.1% |
| 2025-03-31 | 3,088 | 2,437 | 78.9% | — | 703 | 229 | 451 | 14.6% |
| 2024-12-31 | 2,957 | 2,326 | 78.7% | — | 773* | — | 374 | 12.6% |
| 2024-09-30 | 2,797 | 2,213 | 79.1% | — | — | — | 418 | 14.9% |
| Prior TTM | 12,057 | — | — | — | — | — | 1,601 | 13.28% |
* Not used; S&M for the prior-year TTM was not reconstructed inside the time box.
Verified against the filing line by line for Q2 2026: subscription revenue $3,877m, professional services $110m, total cost of revenues $1,169m (subscription $1,030m, services $139m), gross profit $2,818m, S&M $1,372m, R&D $915m, G&A $369m, total operating expenses $2,656m, income from operations $162m, interest income $70m, other income (expense) net +$206m, income before taxes $438m, tax $140m, net income $298m, basic EPS $0.29. Every figure ties.
TTM is used, not last fiscal year. FY2025 revenue was $13,278m; using it would understate the base by 11.0%.
sellingGeneralAndAdministrative carries G&A only| Period | AV sellingGeneralAndAdministrative |
Filed SG&A (S&M + G&A) | Error |
|---|---|---|---|
| NOW 2026-06-30 | $369m | $1,741m (S&M $1,372m + G&A $369m) | 4.72x / $1,372m understated |
| NOW TTM | $1,280m | $6,074m | 4.75x |
AV's field is the G&A line alone; the entire sales-and-marketing expense is absent from it. AV's
operatingExpenses total is correct ($2,656m, ties to the filing), so grossProfit − operatingExpenses =
operatingIncome reconciles and every internal consistency check passes.
Why this is severe. The framework's mandated terminal-margin bridge is
m_EBIT,T = m_gross,T − R&D − S&M − G&A − other. Built from AV fields alone it becomes
74.77% − 22.14% − 8.69% = 43.9% — because S&M reads as zero — against the true 74.77% − 32.54% − 22.14% −
8.69% = 11.40%. A 32.5pp error on the exact parameter this project has already broken five times. This is
the brief's defect #2 in its purest form: a vendor that is wrong consistently defeats every consistency test.
Not in known-silent-failures.md. Reproduced on INTU (4.77x). Recommend adding.
ebit is not operating income| Period | AV ebit |
Filed income from operations | Error |
|---|---|---|---|
| NOW 2026-06-30 | $504m | $162m | 3.11x / $342m overstated |
| NOW 2026-03-31 | $673m | $503m | 1.34x |
| NOW 2025-09-30 | $700m | $572m | 1.22x |
AV computes ebit = incomeBeforeTax + interestExpense (438 + 66 = 504). On NOW that silently absorbs the
+$206m of non-operating "other income (expense), net" — a strategic-investment gain — plus $70m of interest
income. Using AV's ebit as the operating-margin numerator gives a Q2 2026 operating margin of 12.6% against
the filed 4.1% — an 8.5pp error, and it would have concealed the entire purchase-accounting story.
Same family as the brief's warning about ebitda, but on a different field and larger in relative terms.
The brief names ebitda; ebit is equally unsafe and is not currently flagged. Recommend adding.
ebitda unusableNOW 2026-06-30: AV ebitda $911m. Computed from the cash-flow statement as operating income plus |D&A|:
$162m + $407m = $569m. AV's figure is its own (wrong) ebit plus D&A. Never used. The brief's warning
holds on two more names.
AV commonStockSharesOutstanding 1,037m vs the 10-Q's 1,033.862m — 0.3% high. Immaterial, but reported
rather than silently adopted. The company's own diluted figure (1.04bn, from the guidance table) is used.
EARNINGS_ESTIMATES returns an empty arrayEARNINGS_ESTIMATES for NOW returns {"symbol":"NOW","estimates":[]}. Same for INTU. The premium
entitlement's headline feature — built-in 7/30/60/90-day revision history — is unavailable on two names above
$90bn of market capitalisation. Consensus Criteria is therefore INDETERMINATE, which per criteria.md blocks
nothing. No consensus figure was substituted from another source and none was invented.
av_vs_edgar.py reports a rate limit as missing datasym cmp dis worst inv trust
INTU -- -- -- -- AV_NO_QUARTERLY: Minute-level rate
NOW -- -- -- -- AV_NO_QUARTERLY: Minute-level rate
clean: 0/2 failed audit: 0 no EDGAR overlap: 0
The script hit Alpha Vantage's per-minute burst limiter and reported AV_NO_QUARTERLY — "no quarterly data" —
rather than "rate limited." AV had 64 quarterly periods for NOW and 81 for INTU; the data was there. It also
reported clean: 0/2 · failed audit: 0, which reads as "nothing wrong found" when in fact nothing was checked.
This is calibration item D1 — "existence is not validity" — occurring inside the audit tool built to catch D1. The mandated cross-check was performed by hand instead: every Q2 2026 income-statement line, the balance sheet, the share count and the EPS were verified against the filed 10-Q, and defects AV-1 through AV-4 were found that way. Recommend the script distinguish a rate-limit response from an empty response and retry with backoff.
| Input | Screen | Verified | Assessment |
|---|---|---|---|
| Demonstrated revenue CAGR | 22.4% | 22.5% (3y TTM), 23.3% (5y TTM) | Validated. |
| Required CAGR | 22.8% | 35.7% at my terminal margin and an identity-derived 12.5x exit | The screen's figure is reproducible only at an exit multiple near 21x. See below. |
| Margin | −0.4pp | −13.2pp | Direction identical, magnitude 33x wider. The FAIL is real and more robust than the screen suggested. |
| Valuation verdict | FAIL | FAIL | Confirmed. |
| Share count / split basis | — | 1,033.862m post-5-for-1 (effective 2025-12-17); Alpaca prices split-adjusted | Explicitly checked. The CRWD 4.0x pre-/post-split basis mismatch does NOT recur. |
| Net cash | — | −$810m | Cash $2,503m + ST investments $2,161m + LT marketable securities $2,043m − debt $7,517m. Alternatives disclosed: +$1,263m including strategic investments; −$1,746m treating leases as debt. |
| TTM revenue | — | $14,732m | Four quarterly periods summed. FY2025 alone would be $13,278m, 11.0% low. |
| Growth trend | — | Reported +24.0%; organic ~21–22% | Contaminated by $11.3bn of M&A closing inside the window. Materially smaller than PANW's 16.9pp, so the CAGR survives — but any ACCELERATING label on the reported figure would be wrong. |
| Operating margin | — | TTM 11.40%, down from 13.28%; latest quarter 4.1% | Any screen keyed on GAAP margin change scores NOW as deteriorating. Non-GAAP was flat at 29.4% vs 29.7% and is guided to 31.5%. The difference is entirely purchase accounting. |
| Gross margin | — | 74.77% TTM, 70.7% latest quarter | The 6.8pp YoY drop is ~1.5pp intangible amortisation in cost of revenue and ~2.1pp genuine cloud/AI cost inflation, which management guides as permanent. |
Reproducing the screen's −0.4pp. From the sensitivity grid in NOW_Valuation.md, required CAGR 22.6% occurs at
a 20.8x exit multiple with a 23.0% terminal margin. The screen's near-miss was produced by an exit multiple
8.4x above what the reinvestment identity EV_T/EBIT_T = (1−t)(1−g/ROIC)/(WACC−g) warrants — not by the terminal
margin. That is a different failure mode from the five recorded terminal-margin defects and worth logging as
such: the exit multiple, not the terminal margin, was the unexamined parameter on this name.
valuation.md rule 1: assert, never clamp)| Field | Value |
|---|---|
terminal_margin |
0.230 |
terminal_margin_source |
own_opex_bridge_plus_company_guidance |
| Raw trailing value | 0.1140 (TTM GAAP), 0.1374 (FY2025), ~0.155 (cleaned of transitory charges) |
| Transformation | Four-line forward opex bridge; no clamp, no percentile, no industry median, no max() applied |
| Bridge | 0.755 gross − 0.270 S&M − 0.190 R&D − 0.065 G&A = 0.230 |
Constraint m_EBIT,T ≤ m_gross,T |
0.230 ≤ 0.755 ✓ (52.5pp headroom) |
| Relation to own trailing actual | +11.6pp above reported TTM; +7.5pp above cleaned. Not below — the recorded defect does not occur. |
| Non-GAAP cross-check | 0.34 non-GAAP − 0.095 SBC − 0.015 amortisation = 0.230; SBC leg is the company's own published commitment ("less than 10% of revenue by 2029", FAD 2026-05-04) |
| Largest single judgement | The SBC leg. At today's 16.4% the terminal margin is ~16.5% and the Valuation Criteria fails wider. |
evidence_grade |
A |